This work defines a novel tumor‐suppressive E3 ubiquitin ligase RING finger protein 182 (RNF182) which induces ubiquitination and degradation of p65 and consequently suppresses the transcription of programmed death ligand 1, therefore, alleviating immunosuppression and cancer development. The gene discussed is RNF182; the disease is neoplasm.